Neurol. praxi. 2022;23(1):42-45 | DOI: 10.36290/neu.2021.063

Acquired neuropathies in children

MUDr. Katarína Tabačáková, MUDr. Eva Trúsiková, MUDr. Katarína Okáµová, PhD., prof. MUDr. Karol Králinský, PhD.
II. detská klinika SZU, Detská fakultná nemocnica s poliklinikou Banská Bystrica

Neuropathy (peripheral nerve damage) is divided into mononeuropathy (involvement of one peripheral nerves) and polyneuro­pathy (two or more affected nerves) often referred to simply as neuropathy. The main causes of mononeuropathy in children are injuries. In polyneuropathies, the causes are mainly hereditary, followed by immune-mediated neuropathies (dysimmune/autoimmune), neuropathies in acute infections, toxic (most often in cancer treatment), malnutrition and metabolism. Although acquired neuropathies in children are relatively rare, the damage becomes irreversible and mutilating at a misdiagnosis. Only early diagnosis and treatment can reverse this process.

Keywords: acquired neuropathies in children, immune-mediated polyneuropathy, neuropathies in malignancies and others.

Received: July 20, 2021; Revised: August 29, 2021; Accepted: August 30, 2021; Prepublished online: August 30, 2021; Published: March 14, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tabačáková K, Trúsiková E, Okáµová K, Králinský K. Acquired neuropathies in children. Neurol. praxi. 2022;23(1):42-45. doi: 10.36290/neu.2021.063.
Download citation

References

  1. Bednařík J. Chronická zánětlivá demyelinizační neuropatie. Neurol. praxi. 2016;17(1):16-21. Go to original source...
  2. Brizzi KT, Lyons JL. Peripheral nervous system manifestations of infectious disease. The Neurohospitalist. 2014;4(4):230-240. Go to original source... Go to PubMed...
  3. Carrera-Garcia L, Natera-de Benito D, Lleixá C, et al. Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child. Neurology: Neuroimmunology&Neuroinflammation. 2019;6(5):1-3. Go to original source... Go to PubMed...
  4. Cibulčík F. Polyradiculoneuritis Guillain Barré. Neurol. praxi. 2016;17(1):11-15. Go to original source...
  5. Eftimov F, Lucke IM, Querol LA, et al. Uptade Diagnostic challanges in chronic inflammatory demyelinating polyradiculoneuropathy. Brain. 2020;143:3214-3224. Go to original source... Go to PubMed...
  6. Ehler E. Chronická zánětlivá demyelinizační polyradikuloneuropatie. Cesk Slov Neurol N. 2018;81/114(3):252-265. Go to original source...
  7. Humhej I, Ibrahim I, Sameą M, et al. Zobrazení periférních nervů pomocí difúzního tenzoru a MR traktografie. Cesk Slov Neurol N. 2018;81/114(4):420-426. Go to original source...
  8. Christy A. COVID-19: A review for the pediatric neurologist. Journal of child neurology. 2020;35(13):934-939. Go to original source... Go to PubMed...
  9. Korinthenberg R, Trollmann R, Felderhoff-Müser U, et al. Diagnosis and treatment of Guillan-Barré syndrome in childhood and adolescence: An evidence -and consensus - based guideline. European Journal of Paediatric Neurology. 2020;25:5-16. Go to original source... Go to PubMed...
  10. Kraus J, Perníková I, Broľová M. Periferní neuropatie u dětí. Neurol. praxi. 2018;19(3):175-182. Go to original source...
  11. Leypoldt F, Wandinger KP. Paraneoplastic neurological syndromes. Clinical and experimental immunology. 2013;175:336-348. Go to original source... Go to PubMed...
  12. Pi»ha J. Imunoadsorbce v terapii neurologických onemocnění. Neurol. praxi. 2018;19(1):37-40. Go to original source...
  13. ©palek P. Multifokálna motorická neuropatia. Neurol. praxi. 2016;17(1):22-27. Go to original source...
  14. Varadharaju N, Jeevarathnam D, Rajan M, et al. A case of treatment-induced neuropathy in an adolescent with type 1 diabetes. Ann Pediatr Endocrinol Metab. 2019;24:203-206. Go to original source... Go to PubMed...
  15. Wilmshurst JM, Ouvrier RA, Ryan MM. Peripheral nerve disease secondary to systemic conditions in children. Ther Adv Neurol Disord. 2019;12:1-24. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.